ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO122

Impact of Ultrafiltration Rate Among Adults with AKI Treated with Continuous Renal Replacement Therapy (CRRT)

Session Information

  • AKI: Outcomes, RRT
    November 03, 2023 | Location: Exhibit Hall, Pennsylvania Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Authors

  • Gunning, Samantha, University of Chicago Division of the Biological Sciences, Chicago, Illinois, United States
  • Koyner, Jay L., University of Chicago Division of the Biological Sciences, Chicago, Illinois, United States
Background

Observational data supports the view that fluid removal with dialysis in critical illness confers survival benefit. The optimal fluid removal rate is unknown with some suggesting that ultrafiltration rate (UFR) greater than 1.75 mL/kg/hr may be harmful.

Methods

We conducted a single-center retrospective cohort study among adult AKI patients admitted to the intensive care unit (ICU) at University of Chicago treated with CRRT from April 1, 2016 to March 31, 2020. We collected information regarding patient demographics, severity of illness, daily fluid balance (all intakes minus outputs, inclusive of RRT), RRT ultrafiltration, and outcomes (length of stay, dialysis dependence, and mortality). We calculated UFR restricted to the first 72 hours of dialysis treatment as net ultrafiltrate (mL) per hour treatment duration adjusted for patient’s baseline body weight.

Results

742 patients had low UFR (<1.01 mL/kg/hr), 269 had moderate UFR (between 1.01 and 1.75 mL/kg/hr), and 167 had high UFR (>1.75 mL/kg/hr). Those with low UFR were older, had higher baseline body weight, and had less positive fluid balance in the 72 hours prior to starting dialysis. Severity of illness (SOFA) and burden of co-morbidities were not significantly different across UFR groups. Those with low UFR had a median cumulative fluid balance of 2.38 L over 72 hours, lower likelihood to remain dependent on dialysis at 90-days, and highest 90-day mortality (Table 1). In an adjusted Cox proportional hazards model, low UFR was associated with an increased risk of 90-day mortality (HR 1.88, 95% CI 1.10-3.21 p=0.02) whereas high UFR was not significantly associated with 90-day mortality (HR 0.66, 95% CI 0.31-1.42, p=0.29).

Conclusion

Low UFR is associated with increased 90-day mortality while high UFR was not associated with 90-day mortality. Future studies should investigate the ideal UFR to improve patient outcomes.

Outcomes By 72 Hour Net Ultrafiltration Rate
 Low NUF
<1.01 ml/kg/hr
Moderate NUF
1.01-1.75 ml/kg/hr
High NUF
>1.75 ml/kg/hr
p-value
N742269167 
72H Fluid Balance (L),
med (IQR)
2.38 (-0.02, 5.97)-0.62 (-3.33, 2.37)-3.25 (-5.38, -0.35)<0.001
72H UFR (mL/kg/hr), med (IQR)0.39 (0.07, 0.71)1.29 (1.14, 1.47)2.27 (1.93, 2.76)<0.001
ICU Days, med (IQR)8 (3, 19)12 (6, 24)13 (5, 25)<0.001
Hospital Days, med (IQR)14 (5, 27)19 (9, 33)19 (9, 31)<0.001
RRT at Day 90 (%)
Survivors, N=403
31 (14.3)13 (12.1)16 (20.3)0.016
90-Day Mortality (%)525 (70.8)162 (60.2)88 (52.7)<0.001

Funding

  • Commercial Support – Fresenius Medical Care